These findings correlate with our in vitro results and support the concept that Ki67 and p27Kip1 expression levels are important potential biomarkers in δ-tocotrienol treatment of pancreatic cancer. The gene discussed is CDKN1B; the disease is familial pancreatic carcinoma.